Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

Statin use and risk of breast cancer: a meta-analysis of observational studies

(2012) Krishna Undela et al.   BREAST CANCER RESEARCH AND TREATMENT

Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents

(2012) M. Thurnher et al.   CLINICAL CANCER RESEARCH

Statin Use and Reduced Cancer-Related Mortality

(2012) Sune F. Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy

(2012)   PLoS One

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

(2011) Quinci Romero et al.   BMC CANCER

A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

(2011) Michaela J. Higgins et al.   BREAST CANCER RESEARCH AND TREATMENT

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study

(2011) T. P. Ahern et al.   JNCI-Journal of the National Cancer Institute

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells

(2010) G. Gruenbacher et al.   CANCER RESEARCH

Dysregulation of the mevalonate pathway promotes transformation

(2010) J. W. Clendening et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

(2009) Elisabeth R. Garwood et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular mechanisms involved in farnesol-induced apoptosis

(2009) Joung Hyuck Joo et al.   CANCER LETTERS

Estrogen Receptor-Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users

(2008) A. S. Kumar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HMG‐CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors

(2008) Signe Borgquist et al.   INTERNATIONAL JOURNAL OF CANCER